EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Low capacity for molecular detection of Alphaviruses other than Chikungunya virus in 23 European laboratories, March 2022

Laura Pezzi iD, Ramona Moegling, Cécile Baronti, Kamelia R Stanoeva iD, Lance D Presser iD, Pauline Jourdan, Nazli Ayhan, Willem M R van den Akker iD, Stephan Zientara, Céline M Gossner iD, Rémi N Charrel iD, Chantal B E M Reusken und 1 weitere

PLOS ONE · 27.02.2025 · 20 (2) · e0318602

DOI: 10.1371/journal.pone.0318602 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 27.02.2025. Verfasst von Laura Pezzi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Unité des Virus Emergents (UVE: Aix-Marseille Univ, Universita di Corsica, IRD 190, Inserm, IRBA), Corsica, France. Hauptthemen laut MEDLINE: Alphavirus, Alphavirus Infections, Laboratories. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Centre for Disease Prevention and Control, European Union’s Horizon 2020 research and innovation programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alphaviruses comprise over 30 identified species spread worldwide and carry a large global health burden. With vector expansion occurring in and around Europe, it is anticipated this burden will increase. Therefore, regular assessment of the diagnostic capabilities in Europe is important, e.g., by conducting external quality assessments (EQAs). Here we evaluated molecular detection of alphaviruses in expert European laboratories by conducting an EQA in March 2022. Molecular panels included 15 samples: nine alphaviruses, Barmah Forest virus (BFV), chikungunya virus (CHIKV), Eastern equine encephalitis virus (EEEV), Mayaro virus (MAYV), o’nyong-nyong virus (ONNV), Ross River virus (RRV), Sindbis virus (SINV), Venezuelan equine encephalitis virus (VEEV), and Western equine encephalitis virus (WEEV) and four negative control samples. Alphavirus detection was assessed among 23 laboratories in 16 European countries. Adequate capabilities were lacking for several viruses, and approximately half of the laboratories (11/23) relied on pan-alphavirus assays with varying sensitivity and specificity. Only 46% of laboratories characterized all EQA samples correctly. Correct result rates were > 90% for CHIKV, RRV and SINV, but laboratories lacked specificity for ONNV and MAYV and sensitivity for VEEV, BFV, and EEEV. Only two alphaviruses causing human disease circulate or have circulated in Europe, CHIKV and SINV. Molecular detection was satisfactory with both CHIKV and SINV, but < 50% correct for the entire alphaviruses panel. With continued imported cases, and a growing global concern about climate change and vector expansion, focus on progress toward rapid, accurate alphavirus diagnostics in Europe is recommended, as well as regular EQAs to monitor quality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlphavirusAlphavirus InfectionsLaboratoriesEuropeChikungunya virusHumansAnimalsChikungunya Fever

Autor:innen und Institutionen

  • Unité des Virus Emergents (UVE: Aix-Marseille Univ, Universita di Corsica, IRD 190, Inserm, IRBA), Corsica, France.
  • National Reference Center for Arboviruses, National Institute of Health and Medical Research (Inserm) and French Armed Forces Biomedical Research Institute (IRBA), Marseille, France.
  • Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
  • Agency for Food, Environmental and Occupational Health and Safety (ANSES), Maison Alfort, France.
  • Disease Programme Unit, European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.
  • Laboratoire Infections Virales Aigues et Tropicales, APHM Hôpitaux Universitaires de Marseille, Marseille, France.

ORCID-Profile: Laura Pezzi, Kamelia R Stanoeva, Lance D Presser, Willem M R van den Akker, Céline M Gossner, Rémi N Charrel

Förderung

  • European Centre for Disease Prevention and Control
  • European Union’s Horizon 2020 research and innovation programme

Zitieren

APA

Pezzi, L., Moegling, R., Baronti, C., Stanoeva, K. R., Presser, L. D., Jourdan, P., Ayhan, N., van den Akker, W. M. R., Zientara, S., Gossner, C. M., Charrel, R. N., Reusken, C. B. E. M., & EVD-LabNet (2025). Low capacity for molecular detection of Alphaviruses other than Chikungunya virus in 23 European laboratories, March 2022. PLOS ONE, 20(2), e0318602. https://doi.org/10.1371/journal.pone.0318602

Vancouver

Pezzi L, Moegling R, Baronti C, Stanoeva KR, Presser LD, Jourdan P, et al. Low capacity for molecular detection of Alphaviruses other than Chikungunya virus in 23 European laboratories, March 2022. PLOS ONE. 2025;20(2):e0318602. doi:10.1371/journal.pone.0318602

BibTeX
@article{Pezzi2025,
  author = {Pezzi, Laura and Moegling, Ramona and Baronti, Cécile and Stanoeva, Kamelia R and Presser, Lance D and Jourdan, Pauline and Ayhan, Nazli and van den Akker, Willem M R and Zientara, Stephan and Gossner, Céline M and Charrel, Rémi N and Reusken, Chantal B E M and EVD-LabNet, EVD-LabNet},
  title = {Low capacity for molecular detection of Alphaviruses other than Chikungunya virus in 23 European laboratories, March 2022},
  journal = {PLOS ONE},
  year = {2025},
  volume = {20},
  number = {2},
  pages = {e0318602},
  doi = {10.1371/journal.pone.0318602}
}
Kostenlos starten →